{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-059545","form_type":"8-K","ticker":"RNTX","cik":"0001420565","company_name":"Rein Therapeutics, Inc.","filed_at":"2026-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.042821+00:00","generated_at":"2026-05-16T01:42:22.154249+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Manuel C. Alves Aivado resigns from Rein Therapeutics board effective Feb 16","bullets":["Manuel C. Alves Aivado, M.D., Ph.D., resigned as board member effective February 16, 2026.","Resignation was not the result of any disagreement with the company's operations, policies, or practices.","No replacement has been announced; board size and composition subsequent to departure not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-059545","json":"https://secwatch.observer/filing/0001193125-26-059545.json","markdown":"https://secwatch.observer/filing/0001193125-26-059545.md","text":"https://secwatch.observer/filing/0001193125-26-059545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526059545/0001193125-26-059545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420565/000119312526059545/d31606d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:42:22.154249+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}